novo nordisk ozempic - Search News

News

Novo Nordisk, compounders

Novo Nordisk expands lawsuits against weight-loss drug compounders

By Christy Santhosh (Reuters) -Danish drugmaker Novo Nordisk said on Tuesday it has filed 14 new lawsuits in the United States against the sale of unapproved versions of semaglutide, the active ingredient in its popular weight-loss and diabetes drugs,

Bloomberg on MSN · 1d

How Novo Nordisk Gave Up Its Weight-Loss Gains

For a while, Danish drugmaker Novo Nordisk A/S looked unstoppable. It was at the forefront of the weight-loss injection boom as people discovered that its Ozempic shot, originally developed to treat diabetes,

MarketWatch on MSN · 16h

Novo Nordisk is no longer a buy at UBS, which says compounding is here to stay

Novo Nordisk, the Danish maker of the wildly popular Ozempic and Wegovy drugs used for weight loss, was downgraded due to competition from compounding as well as arch rival Eli Lilly, a brokerage said on Tuesday.

Novo Nordisk Faces Ozempic-Linked Securities Fraud Claims

Levi & Korsinsky is representing the shareholder plaintiff in a suit claiming the Ozempic and Wegovy manufacturer withheld ...

Fierce Pharma13h

Novo Nordisk faces investor lawsuit over 'false and misleading' semaglutide sales projections

Novo Nordisk underestimated the impact of competition from personalized compounded drugs when providing sales estimates for ...

4hon MSN

Ozempic could be hurting your gym gains — with potentially dangerous consequences

Muscle and strength loss in human aging, also known as sarcopenia, can result in trouble with balance and walking, according ...

8hon MSN

Why Novo Nordisk Stock Is Down Again Today

Weston's downgrade still values Novo Nordisk stock above its current share price of $47 and change, however. Moreover, Novo ...

24/7 Wall St.7d

Ozempic Maker Novo Nordisk Is Plunging 20%. Time to Sell or Buy More?

Danish pharmaceutical giant Novo Nordisk (NYSE:NVO) is watching its stock plummet 20% in morning trading after slashing its ...

6don MSN

Ozempic maker Novo Nordisk has its worst day since Black Monday

Shares of Novo Nordisk skidded on Tuesday as the Danish drugmaker reduced its expectations on wildly popular drugs Ozempic ...

Ozempic Maker’s Stock Plunges 20% After Profit Warning

Novo Nordisk slashed its financial forecasts as it struggled to fight off competition in the United States. It also named a ...

13m

Will Hims & Hers Fall Along With Novo Nordisk?

Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.

Novo Nordisk: I Was Wrong Twice, But This Selloff Looks Like 2016 All Over Again

Novo Nordisk is attractively valued after the sell-off, but near-term recovery requires patience. Read why I'm downgrading ...

13h

Novo Nordisk to Disclose Full Second-Quarter Earnings Amid Management Reshuffle -- Earnings Preview

Novo Nordisk is scheduled to report results for the second quarter on Wednesday. Here is what you need to know: PROFIT FORECAST: The company pre-released preliminary second-quarter numbers last week, ...

10hon MSN

Novo Nordisk Stock Catches a Downgrade. The Eli Lilly Threat Is Just One Reason.

Novo Nordisk stock was downgraded to Neutral from Buy by UBS analysts, who cited the threat posed by its U.S. rival.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results